Efficacy and Safety of Dapagliflozin as Adjunct Therapy in Patients with Type 2 Diabetes Mellitus Inadequately Controlled on Metformin and Sulfonylurea. ajm. 2026;9(2):201-205. doi:10.48165/ajm.2026.9.02.34